Results
75,408 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Phillips GeoffreySr. VP, Operations |  GATXGATX CORPGift | G | — 6,472 sh | Sep 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Phillips GeoffreySr. VP, Operations | GATXGATX CORP Gift | G | — 6,472 sh | Sep 4, 2026 |
| 12 | O'Neill Kevin MichaelCEO, PDx |  GEHCGE HealthCare Technologies Inc.Tax withholding | F | $51K 718 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 12 | Kass-Hout TahaChief Technology Officer | GEHCGE HealthCare Technologies Inc. Tax withholding | F | $106K 1,502 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 12 | Holland Noel R.Director |  CLBKColumbia Financial, Inc./MD/Gift | G | — 20 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 12 | Jain AjitDirector, Vice Chairman |  BRK.ABERKSHIRE HATHAWAY INCGift | G | — 10 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 12 | Dozier EricEVP, Chief People Officer |  LLYELI LILLY & CoGift | G | — 216 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 12 | Wessling Erin MEVP & Chief Legal Officer |  ELVElevance Health, Inc.Tax withholding | F | $106K 255 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 12 | Wininger ShaiDirector, President |  LMNDLemonade, Inc.Gift | G | — 1,876 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 11 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER |  EDITEditas Medicine, Inc.Open-market sale · 10b5-1 plan | SELL | $2,153 709 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 11 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $313K 9,180 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 11 | Parison AmySVP, Chief Financial Officer | EDITEditas Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $1,376 453 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 11 | O'Neill Gilmore NeilDirector, CEO | EDITEditas Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $16K 5,124 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 11 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer |  WRBYWarby Parker Inc.Tax withholding | F | $572K 23.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 10 | Thornberry NancyDirector |  DNLIDenali Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $15K 615 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Argen JohnDirector |  DTSTData Storage CorpOption exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Collins John DeNeenCFO and COO |  LPSNLIVEPERSON INCDisposition to issuer | D | — 6,260 sh | Sep 4, 2026 traded Sep 4, 2026 |
| 9 | Holton Adam YChief People Officer | GEHCGE HealthCare Technologies Inc. Tax withholding | F | $47K 673 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Kim JoyceDirector |  QUIKQUICKLOGIC CorpOption exercise | M | — 5,246 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Ware J. AnthonyDirector |  TRAXFirst Tracks Biotherapeutics, Inc.Option exercise | M | — 10.7K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Chambers RebeccaChief Financial Officer |  VCYTVERACYTE, INC.Open-market sale · 10b5-1 plan | SELL | $106K 2,477 sh | Sep 4, 2026 traded Sep 4, 2026 |
| 9 | Gilboa David AbrahamDirector, Co-Chief Executive Officer | WRBYWarby Parker Inc. Option exercise | M | — 44.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Naos YaronSr. VP & COO |  PLXProtalix BioTherapeutics, Inc.Grant or award | A | — 56.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer | WRBYWarby Parker Inc. Option exercise | M | — 11.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Pace Philip JSVP, Chief Accounting Officer |  BLMNBloomin' Brands, Inc.Option exercise | M | — 15.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Fletcher DanDirector | LPSNLIVEPERSON INC Disposition to issuer | D | — 18.7K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 9 | Naos YaronSr. VP & COO | PLXProtalix BioTherapeutics, Inc. Grant or award | A | — 112.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Correll Todd A.Director | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Collins John DeNeenCFO and COO | LPSNLIVEPERSON INC Disposition to issuer | D | — 81.1K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 9 | Bashan DrorDirector, PRESIDENT AND CEO | PLXProtalix BioTherapeutics, Inc. Grant or award | A | — 320.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Grover MatthewDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Lefferts KellyEVP, Chief Legal Officer | BLMNBloomin' Brands, Inc. Option exercise | M | — 15.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Maglione Lawrence A.Director | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer | WRBYWarby Parker Inc. Option exercise | M | — 44.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Stein CliffordDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Kempster ThomasDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Stallone NancyDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Estrampes CatherineChief Commer. & Growth Officer | GEHCGE HealthCare Technologies Inc. Tax withholding | F | $36K 508 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Frieson DonaldDirector |  CASYCASEYS GENERAL STORES INCOption exercise | M | — 326 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Mitchell Uwayne A.Director | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Grover MatthewDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |